Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies

References

• Stegemann S, Leveiller F, Franchi D, et al. When poor solubility becomes an issue: from early stage to proof of concept. Eur J Pharm Sci. 2007;3:249–261.
   Web of Science ®Google Scholar
• Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomed Nanotech Biol Med. 2010;6:9–24.
   PubMed Web of Science ®Google Scholar
• Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv. 2011;8:1407–1424.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Gao F, Bu H, et al. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomed Nanotech Biol Med. 2012;8:740–747.
   PubMed Web of Science ®Google Scholar
• Minassian A, Young JW. Evaluation of the clinical efficacy of asenapine in schizophrenia. Expert Opin Pharmacother. 2010;11:2107–2115.
   PubMed Web of Science ®Google Scholar
• Patel M, Sawant K. A quality by design concept on lipid based nanoformulation containing antipsychotic drug: screening design and optimization using response surface methodology. J Nanomed Nanotechnol. 2017;8:1–11.
   Google Scholar
• Das S, Ng WK, Kanaujia P, et al. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surface B. 2011;88:483–489.
   PubMed Web of Science ®Google Scholar
• Soares S, Fonte P, Costa A, et al. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles. Int J Pharm. 2013;456:370–381.
   PubMed Web of Science ®Google Scholar
• Natarajan J, Baskaran M, Humtsoe LC, et al. Enhanced brain targeting efficacy of olanzapine through solid lipid nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45:364–371.
   PubMed Web of Science ®Google Scholar
• Sawant KK, Patel MH, Patel K. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations. Drug Dev Ind Pharm. 2016;42:758–768.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine. 2009;5:184–191.
   PubMed Web of Science ®Google Scholar
• Shi LL, Cao Y, Zhu XY, et al. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model. Int J Pharm. 2015;478:60–69.
   PubMed Web of Science ®Google Scholar
• Rajpoot K, Jain SK. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation. Artif Cells Nanomed Biotechnol. 2018;46:1236–1247.
   PubMed Web of Science ®Google Scholar
• Xiao B, Han MK, Viennois E, et al. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Nanoscale. 2015;7:17745–17755.
   PubMed Web of Science ®Google Scholar
• Rivolta I, Panariti A, Lettiero B, et al. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. J Physiol Pharmacol. 2011;62:45–53.
   PubMed Web of Science ®Google Scholar
• Jain A, Barve A, Zhao Z, et al. Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery. Mol Pharm. 2017;14:1517–1527.
   PubMed Web of Science ®Google Scholar
• Shah MK, Madan P, Lin S. Elucidation of intestinal absorption mechanism of carvedilol-loaded solid lipid nanoparticles using Caco-2 cell line as an in vitro model. Pharm Dev Technol. 2015;20:1–9.
   PubMed Web of Science ®Google Scholar
• Beloqui A, Solins M. n, Gascn AR, et al. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Control Release. 2013;166:115–123.
   PubMed Web of Science ®Google Scholar
• Parthasarathi TR, Srinivas TS, Sri MV, et al. Quantitative determination of asenapine maleate using reverse phase-high performance liquid chromatography. In J Pharm Bio Sci. 2012;3:360–366.
   Google Scholar
• Jose S, Anju SS, Cinu TA, et al. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int J Pharm. 2014;474:6–13.
   PubMed Web of Science ®Google Scholar
• Memvanga PB, Coco R, Preat V. An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether. J Control Release. 2013;172:904–913.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Aditya N, Kathuria H, et al. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur J Pharm Biopharm. 2014;87:114–124.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Mohammadi MY. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. J Liposome Res. 2010; 20:286–296.
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci. 2005;24:381–388.
   PubMed Web of Science ®Google Scholar
• Wang T, Shen L, Zhang Z, et al. A novel core-shell lipid nanoparticle for improving oral administration of water soluble chemotherapeutic agents: inhibited intestinal hydrolysis and enhanced lymphatic absorption. Drug Deliv. 2017;24:1565–1573.
   PubMed Web of Science ®Google Scholar
• Yasir M, Sara UVS. Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B. 2014;4:454–463.
   PubMed Web of Science ®Google Scholar
• Almeida EDP, Costa AA, Serafini MR, et al. Preparation and characterization of chloroaluminum phthalocyanine-loaded solid lipid nanoparticles by thermal analysis and powder X-ray diffraction techniques. J Therm Anal Calorim. 2012;108:191–196.
   Web of Science ®Google Scholar
• Carvalho SM, Noronha CM, Floriani CL, et al. Optimization of α-tocopherol solid lipid nanoparticles by central composite design. Ind Crops Prod. 2013;49:278–285.
   Web of Science ®Google Scholar
• Venishetty VK, Chede R, Komuravelli R, et al. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surfaces B. 2012;95:1–9.
   PubMed Web of Science ®Google Scholar
• Nabi-Meibodi M, Vatanara A, Najafabadi AR, et al. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method. Colloids Surf B Biointerfaces. 2013;112:408–414.
   PubMed Web of Science ®Google Scholar
• Silva AC, Amaral MH, González-Mira E, et al. Solid lipid nanoparticles (SLN) – based hydrogels as potential carriers for oral transmucosal delivery of risperidone: preparation and characterization studies. Colloids Surf B. 2012;93:241–248.
   PubMed Web of Science ®Google Scholar
• Liang M, Lin I, Whittaker MR, et al. Cellular uptake of densely packed polymer coatings on gold nanoparticles. ACS Nano. 2010;4:403–413.
   PubMed Web of Science ®Google Scholar
• Sha X, Yan G, Wu Y, et al. Effect of self-microemulsifying drug delivery systems containing labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci. 2005;24:477–486.
   PubMed Web of Science ®Google Scholar
• Chai GH, Xu Y, Chen SQ, et al. Transport mechanisms of solid lipid nanoparticles across Caco-2 cell monolayers and their related cytotoxicology. ACS Appl Mater Interfaces. 2016;8:5929–5940.
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen D, Ren L, et al. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release. 2006;114:53–59.
   PubMed Web of Science ®Google Scholar
• Luo CF, Yuan M, Chen MS, et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm. 2011;410:138–144.
   PubMed Web of Science ®Google Scholar
• Fan Z, Wu J, Fang X, et al. A new function of vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons. Int J Pharm 2013;445:41147.
   Web of Science ®Google Scholar
• Moghimipour E, Ameri A, Handali S. Absorption-enhancing effects of bile salts. Molecules. 2015;20:14451–14473.
   PubMed Web of Science ®Google Scholar
• Ekambaram P, Hasan SAA. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm. 2011;3:216–220.
   PubMedGoogle Scholar
• Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™). Int J Pharm. 1998;168:221–229.
   Web of Science ®Google Scholar